The BioProcess Insider Expression Platform
GSK’s Digital Twin Approach to Vaccine Development, with Matt Harrison

GSK’s Digital Twin Approach to Vaccine Development, with Matt Harrison

August 9, 2021

A digital twin is a virtual representation that serves as the real-time digital counterpart of a physical object or process. Biopharma giant GlaxoSmithKline (GSK) has adopted this technology to advance its vaccine development and manufacturing division.

A year after partnering with Siemens and Atos to pilot a digital twin in order to create a real-time simulation of the entire vaccine manufacturing process, we sat down (virtually, sadly) with Matt Harrison, head of Sciences, Digital Innovation and Business Strategy at GSK to discuss the current status of this project.

 

Keep up with BioProcess Insider on our website.

Follow us on LinkedIn and Twitter:

On Board the Cell Shuttle with Cellares’ Fabian Gerlinghaus

On Board the Cell Shuttle with Cellares’ Fabian Gerlinghaus

May 10, 2021

Having raised $82 million in its latest funding round, tech firm Cellares Corporation is looking to advance development of its cell therapy manufacturing platform, the Cell Shuttle.

 

We spoke with co-founder and CEO Fabian Gerlinghaus about the current limitations in CAR-T production and how the Cell Shuttles’ scalable, modular, and automated nature could be a gamechanger in the burgeoning space

 

Keep up with BioProcess Insider on our website.

Follow us on LinkedIn and Twitter:

 

The Future of Cell and Gene Therapies, with E&Y’s Adlai Goldberg

The Future of Cell and Gene Therapies, with E&Y’s Adlai Goldberg

April 21, 2021

The cell and gene therapy sector is on the cusp of flourishing in the vast pharma landscape. Money is flowing in, manufacturing challenges are being overcome, people are actually being treated and cured. Even COVID-19 may be seen as a driving force for the burgeoning sector. But what does the future hold? Ernst & Young’s Adlai Goldberg describes the steps industry must take to advance the advanced therapy space and how it must move to balance the individualized autologous approach with more sustainable allogeneic products.

 

Keep up with BioProcess Insider on our website.

 

Follow us on LinkedIn and Twitter:

Fill & Finish in the time of COVID, with Vinenza Pironti

Fill & Finish in the time of COVID, with Vinenza Pironti

March 30, 2021

Vincenza Pironti - Global SME, Steriles, ThermoFisher Scientific - sits down (at a distance) with editor Dan Stanton to discuss aseptic manufacturing in the current climate and how vaccine and biologic makers can ensure a robust, global fill/finish supply both during the COVID pandemic and beyond

Content is King in bioprocessing and beyond, with Brian Caine

Content is King in bioprocessing and beyond, with Brian Caine

March 10, 2021

After a quarter of a century in the life sciences publishing space, Brian Caine stepped down from his position as publisher of BioProcess International last year. He has played a huge part in the evolution of the trade media and still has his finger on the pulse of the bioprocess space. Here he discusses candidly how content marketing can make or break both advertisers and publications.

From mAbs to cell and gene therapies with Patrick Lucy

From mAbs to cell and gene therapies with Patrick Lucy

February 11, 2021

Having just been appointed chief operating officer of contract manufacturing services organization (MSA) Lykan Bioscience, Patrick Lucy reflects on an illustrious career in the biopharma space and the parallels of today's cell and gene therapy landscape with that of monoclonal antibodies 30 years ago. 

BIEP#1 Diversity in Biopharma with Tia Lyles-Williams

BIEP#1 Diversity in Biopharma with Tia Lyles-Williams

January 20, 2021

Tia Lyles-Williams, CEO of LucasPye Bio,  joins journalist Dan Stanton to talk about diversity in the bopharma workplace and the hurdles that continue to hold back black and minority workers.

Unconscious - or perhaps conscious - bias has held African-Americans and others back in the biomanufacturing space but positive change is on its way not least from Tia's own company, a Philly-based CDMO, which is hoping to help level the playing field

Podbean App

Play this podcast on Podbean App